Nonninger, Tim J.
Mak, Jennifer
Gerisch, Birgit
Ramponi, Valentina
Kawamura, Kazuto
Ripa, Roberto
Schilling, Klara
Latza, Christian
Kölschbach, Jonathan https://orcid.org/0009-0000-5191-4732
Serrano, Manuel
Antebi, Adam https://orcid.org/0000-0002-7241-3029
Article History
Received: 30 January 2024
Accepted: 27 May 2025
First Online: 30 June 2025
Competing interests
: M.S. is shareholder of Senolytic Therapeutics, Life Biosciences, Rejuveron Senescence Therapeutics and Altos Labs. In the past, M.S. has been a consultant (until the end of 2022) of Rejuveron Senescence Therapeutics and Altos Labs. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. The other authors declare no competing interests.